Gene · 156
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kisspeptins and norepinephrine regulate different G-protein-coupled receptor signaling pathways. | Transl Lung Cancer Res | 2022 | 36090646 | PubTator, text mining | PubMed |
| Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C isozymes are involved in mGlu5a receptor internalization. | J Biol Chem | 2022 | 36087841 | PubTator, text mining | PubMed |
| Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD. | Neuron | 2022 | 36087581 | PubTator, text mining | PubMed |
| Mechanisms regulating neutrophil responses in immunity, allergy, and autoimmunity. | Allergy | 2022 | 36067034 | PubTator, text mining | PubMed |
| The tyrosine phosphorylation of GRK2 is responsible for activated D2R-mediated insulin resistance. | Biochem Biophys Res Commun | 2022 | 36063601 | PubTator, text mining | PubMed |
| AAV-mediated gene therapy: Advancing cardiovascular disease treatment. | Front Cardiovasc Med | 2022 | 36061546 | PubTator, text mining | PubMed |
| Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection. | Biomed Pharmacother | 2022 | 36058144 | PubTator, text mining | PubMed |
| Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances and future perspectives. | Eur J Med Chem | 2022 | 36055000 | PubTator, text mining | PubMed |
| The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications. | J Biomed Sci | 2022 | 36050716 | PubTator, text mining | PubMed |
| New Tricks for an Old Dog: Biased GPCR Agonism of an M4 Muscarinic Acetylcholine Receptor Antagonist in Airway Smooth Muscle Cells. | Am J Respir Cell Mol Biol | 2022 | 36049223 | PubTator, text mining | PubMed |
| G protein-coupled receptor kinase 6 (GRK6) regulates insulin processing and secretion via effects on proinsulin conversion to insulin. | J Biol Chem | 2022 | 36030052 | PubTator, text mining | PubMed |
| Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism. | Int J Mol Sci | 2022 | 36012168 | PubTator, text mining | PubMed |
| Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease. | Metabolites | 2022 | 36005590 | PubTator, text mining | PubMed |
| Mycobacterium tuberculosis Utilizes Host Histamine Receptor H1 to Modulate Reactive Oxygen Species Production and Phagosome Maturation via the p38MAPK-NOX2 Axis. | mBio | 2022 | 36000734 | PubTator, text mining | PubMed |
| Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition in Patients With Acute Anterior Myocardial Infarction: Final 1-Year Outcomes of the Randomized CARE-AMI Trial. | J Am Heart Assoc | 2022 | 36000427 | PubTator, text mining | PubMed |
| GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma. | J Exp Clin Cancer Res | 2022 | 35996148 | PubTator, text mining | PubMed |
| CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse. | Front Immunol | 2022 | 35983040 | PubTator, text mining | PubMed |
| Natural medicines of targeted rheumatoid arthritis and its action mechanism. | Front Immunol | 2022 | 35979373 | PubTator, text mining | PubMed |
| The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. | Front Immunol | 2022 | 35967413 | PubTator, text mining | PubMed |
| Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease. | Int J Mol Sci | 2022 | 35955885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/156/papers?page=22